跳至主要内容

The prokaryotic expression system (E. coli expression system)

 The prokaryotic expression system (E. coli expression system) is the earliest developed and most widely used classic expression system in gene expression technology. In recent decades, the E. coli expression system has also been continuously developed and improved, and has been widely used by scientific research and industrial users for various Recombinant protein expression. Compared with other expression systems, it has the characteristics of high expression level of target gene, short culture period, strong anti-pollution ability and relatively low cost.

Medicilon researchers have established a mature E. coli expression and purification service platform to provide expression and purification services including various recombinant proteins and their complexes in E. coli.

Prokaryotic expression system (E. coli expression system) service items:

   ❖Recombinant plasmid construction;

   ❖Recombinant expression test;

   ❖Soluble expression condition test;

   ❖Small-scale protein expression and purification (2L medium culture product);

   ❖Large-scale protein expression and purification (above 10L).

StepExperiment contentExperiment timeRemarks
1Recombinant plasmid constructionfor 2 weeksYou can choose different vectors, different tags His, Trx, GST, SUMO…
2Recombinant expression test1 weekDifferent expression strains are optional
3Soluble expression test1-2 weeksDifferent inducers, induction temperature, can also be reconsidered based on protein  Construction of mutants with structural point mutations or deletion mutations
4Small-scale protein expression and purification1-2 weeksIn case of inclusion body expression, the time and method will be adjusted
5Large-scale protein expression and purificationAccording to the expression volumeIt can be selected from shake flask or fermentor culture

Remarks:

You can choose any of the above experimental content, or a combination of related experimental content according to the experimental needs;

During purification, affinity purification, ion column purification, hydrophobic packing purification and molecular sieve purification are used; the characteristics of the protein itself and the choice of expression system will affect the purity and activity of the final protein;

Related Articles:

protein expression in e coli

Medicilon’s Yeast Two Hybrid Services

评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d

Novel Parkinson’s Therapies Possible with New Mouse Model

Parkinson's disease (PD) is a neurodegenerative disorder that is marked by the accumulation of the protein, α-synuclein (αS), into clumps known as Lewy bodies, which diminish neural health. Now, researchers from Brigham and Women's Hospital (BWH) report the development of a mouse model to induce PD-like αS aggregation, leading to resting tremor and abnormal movement control. The mouse responds to L-DOPA, similarly to patients with PD. The team's study (“Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson’s Disease”) on the use of this transgenic mouse model appears in  Neuron . “α-Synuclein (αS) regulates vesicle exocytosis but forms insoluble deposits in PD. Developing disease-modifying therapies requires animal models that reproduce cardinal features of PD. We recently described a previously unrecognized physiological form of αS, α-helical tetramers, and showed that familial PD-causing missense mutati